Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma

BACKGROUND: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. OBJECTIVE: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking cabergoline for the treatment of prolactinoma and to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Khare, Shruti, Lila, Anurag R., Patil, Rishikesh, Phadke, Milind, Kerkar, Prafulla, Bandgar, Tushar, Shah, Nalini S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240058/
https://www.ncbi.nlm.nih.gov/pubmed/28217516
http://dx.doi.org/10.4103/2230-8210.196010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240058/
https://www.ncbi.nlm.nih.gov/pubmed/28217516
http://dx.doi.org/10.4103/2230-8210.196010

Ejemplares similares